Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Ways To Earn Cash Fast At Home For Free
Looking for ways to earn cash fast at home for free? Check out these straightforward methods to get your finances on track quickly.
22,290 articlesDelivering Global Dividends Gains Draw Retirees' Attention
A new ETF focused on global dividend growers aims to deliver steady income and long-term growth. Retirees weigh modes...
Playing Safe with $1.9: Retiree Shows Persistent Income Gap
A 65-year-old retiree with $1.9 million faces a shrinking sustainable income due to a conservative mix. The case high...
Occidental Petroleum vs Exxon Mobil: Who Leads 2026
Two oil giants enter 2026 with contrasting plays: Occidental Petroleum pares back, focusing on the Permian, while Exx...
Bitmine Plans 9.5% Preferred Stock to Fuel ETH Buyback
Bitmine filed for a public offering of 3 million shares of a 9.50% perpetual preferred stock to accelerate ETH holdin...
Moderna Some Approvals Ahead: Is the Stock a Buy?
Moderna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
Never Medicare Premiums Again: A New Portfolio Plan
As Medicare costs rise in 2026, a diversified income plan offers a path to cover health coverage indefinitely. Expert...
Is This Biotech Stock After Its Massive Rally a Smart Buy?
A biotech stock can surge on hype, but smart investors dig into the data behind the rally. This guide breaks down how...
Millionaire Interview Update: Three-Year Wealth Journey
Three years have passed since a notable millionaire interview. This update reveals how one couple grew their net wort...
Aston Martin Workforce Cut Up to 20% Amid Tariffs
Aston Martin plans a major workforce reduction of up to 20%, affecting about 600 roles from a 3,000-employee base. Th...
The No. 1 Reason to Claim Social Security at Age 62
When retirement planning feels uncertain, claiming Social Security at 62 can provide a reliable income floor. This ar...
Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status